Ms Cathy Botticelli > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
- Firm Profile
- Go to...
Ms Cathy Botticelli
Work Department
Litigation
Career
Catherine (“Cathy”) Botticelli has been listed as a leading attorney in The Best Lawyers in America since 2009 for her work in securities litigation and securities regulation. Clients have told reviewers that she provides “experienced, sage counsel” in defending governmental investigations. The Securities Docket named Ms. Botticelli to its “Enforcement 40 for 2017,” which is Securities Docket’s list of the 40 top securities enforcement defense attorneys in the country. Ms. Botticelli also serves as Deputy Chair of the Talent at the firm and is a member of the firm’s Policy Committee. She formerly co-chaired the firm’s Securities Litigation Group.
Education
Fordham University, B.A., 1985, magna cum laude; Fordham University School of Law, J.D., 1988, Member of the International Law Journal, author of “Recent Canadian Blocking Legislation: A Vehicle To Foster Extraterritorial Discovery Cooperation Between the United States and Canada,” Fordham International Law Journal, Vol. 10 (1987)
Top Tier Firm Rankings
- Environment > Environment: transactional
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Antitrust > Civil litigation/class actions: defense
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > International arbitration
- Tax > International tax
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Investment fund formation and management > Alternative/hedge funds
- Dispute resolution > Financial services litigation